Cutler Group’s Direxion Daily S&P Biotech Bear 3X ETF LABD Stock Holding History
Bought
Maintained
Sold
Other funds holding LABD
BOCH
VF
BC
ASM
GS
SRL
Cutler Group's LABD Position: Q1 2024 in Review
Cutler Group sold out of Direxion Daily S&P Biotech Bear 3X ETF (LABD) in Q1 2024, closing a stake of 10 shares — an estimated $834 sold.
Cutler Group first reported a position in LABD in Q1 2016 and held it in 23 quarters. The position peaked at $405K in Q2 2021. 21 funds tracked by Wall St. Rank hold LABD as of Q1 2024.
- Cutler Group reported no remaining Direxion Daily S&P Biotech Bear 3X ETF position as of Q1 2024 after selling out during the quarter.
- Cutler Group sold 10 Direxion Daily S&P Biotech Bear 3X ETF shares in Q1 2024, an estimated $834.
- Cutler Group first reported a position in Direxion Daily S&P Biotech Bear 3X ETF in Q1 2016 and held it in 23 quarters.
- Cutler Group's Direxion Daily S&P Biotech Bear 3X ETF position peaked at $405K in Q2 2021.
- 21 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bear 3X ETF as of Q1 2024.
Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.